187 related articles for article (PubMed ID: 7365237)
1. In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.
Wheelock EF; Weinhold KJ; Ingenito GG; Goldstein LT
J Immunol; 1980 Apr; 124(4):1642-7. PubMed ID: 7365237
[No Abstract] [Full Text] [Related]
2. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Mar; 44(3):1063-71. PubMed ID: 6607108
[TBL] [Abstract][Full Text] [Related]
3. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Jul; 44(7):2897-906. PubMed ID: 6609767
[TBL] [Abstract][Full Text] [Related]
4. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
Robinson MK; Truitt GA; Okayasu T; Wheelock EF
Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
[TBL] [Abstract][Full Text] [Related]
5. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.
Marsili MA; Robinson MK; Truitt GA; Wheelock EF
Cancer Res; 1983 Jan; 43(1):15-21. PubMed ID: 6600159
[TBL] [Abstract][Full Text] [Related]
6. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
Suzuki Y; Liu CM; Chen LP; Ben-Nathan D; Wheelock EF
J Immunol; 1987 Nov; 139(9):3146-52. PubMed ID: 3117888
[TBL] [Abstract][Full Text] [Related]
7. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
Manson LA
Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
[TBL] [Abstract][Full Text] [Related]
8. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
Chow DA
J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
[TBL] [Abstract][Full Text] [Related]
9. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
Anaclerio A; Waterfield JD; Möller G
J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
[No Abstract] [Full Text] [Related]
10. Alanine inhibits cytotoxic responses: its production by different tumor cell lines explains differences in their immunogenicity.
Dröge W; Wehrmaker A; Eck HP
Cancer Detect Prev; 1988; 11(3-6):151-6. PubMed ID: 3134127
[TBL] [Abstract][Full Text] [Related]
11. Rapidly reversible resistance to immune lysis of L5178Y lymphoma cells in a tumor-dormant state in DBA/2 mice.
Okayasu T; Wheelock EF
J Natl Cancer Inst; 1986 Jun; 76(6):1199-204. PubMed ID: 3458956
[TBL] [Abstract][Full Text] [Related]
12. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
[TBL] [Abstract][Full Text] [Related]
13. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
Migliorati G; Romani L; Fioretti MC
Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
[TBL] [Abstract][Full Text] [Related]
14. Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: in vivo and in vitro effects.
Liu CM; Suzuki Y; Chen LP; Okayasu T; Calkins CE; Wheelock EF
Cancer Res; 1990 Mar; 50(5):1361-7. PubMed ID: 2302701
[TBL] [Abstract][Full Text] [Related]
15. Location of tumoral antigens in L5178Y murine lymphoma cells.
Ramos-Damián ME; Gómez-Estrada H; Hernández-Delgado J; Tapia-Arizmendi L; Feria-Velasco A
Arch Invest Med (Mex); 1980; 11(3):425-34. PubMed ID: 7469659
[TBL] [Abstract][Full Text] [Related]
16. [Participation of soluble H-2 antigens in serological and cellular reactions].
Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
[No Abstract] [Full Text] [Related]
17. Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice.
Wheelock EF; Robinson MK; Truitt GA
Cancer Metastasis Rev; 1982; 1(1):29-44. PubMed ID: 6985247
[TBL] [Abstract][Full Text] [Related]
18. Increase of growth of the L5178Y murine lymphoma by means of immunization with radiated L5178Y cells.
Ramos-Damián M; Gómez-Estrada H; Acosta-Ruiz R; Díaz-Esquivel P; Vázquez-Escobosa C
Arch Invest Med (Mex); 1982; 13(1):29-31. PubMed ID: 7065806
[No Abstract] [Full Text] [Related]
19. A search for target cell structures associated with susceptibility to NK cells.
Henney CS
Adv Exp Med Biol; 1982; 146():357-66. PubMed ID: 7102463
[No Abstract] [Full Text] [Related]
20. Cytogenetic analysis of an immunogenic mutant of the L5178Y lymphoma.
Greenberg AH; Manougian J; Ray M; Goldenberg GJ
Acta Cytol; 1980; 24(3):232-6. PubMed ID: 6773281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
